Nuwellis Announces The Submission Of The AVOID-HF Clinical Analysis As A Late Breaking Clinical Trial At HFSA

Media coverage

• Title	Nuwellis Announces The Submission Of The AVOID-HF Clinical Analysis As A Late Breaking Clinical Trial At HFSA
  Media name/outlet	MENAFN -Press Releases (English)
  Country/Territory	Jordan
  Date	26/07/22
  Persons	Sean Pinney

• Title	Nuwellis Announces the Submission of the AVOID-HF Clinical Analysis as a Late Breaking Clinical Trial at HFSA
  Media name/outlet	Cardiac Vascular News
  Country/Territory	United States
  Date	26/07/22
  URL	cardiacvascularnews.com/nuwellis-announces-the-submission-of-the-avoid-hf-clinical-analysis-as-a-late-breaking-clinical-trial-at-hfsa/
  Persons	Sean Pinney

• Title	Nuwellis Announces the Submission of the AVOID-HF Clinical Analysis as a Late Breaking Clinical Trial at HFSA; The Finkelstein-Schoenfeld Method of Win Ratios Analysis Provides New Insights Into Superiority of Ultrafiltration over Diuretics in Treating Fl
  Media name/outlet	PrimeNewswire (Top News)
  Country/Territory	United States
  Date	26/07/22
  Persons	Sean Pinney